Moderna president exercises 9,283 RSUs on Sept. 1
Moderna President Stephen Hoge reported an RSU vesting and tax-related share withholding on September 1, 2026, with substantial direct and indirect equity positions remaining.
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) reported that President Stephen Hoge exercised 9,283 Restricted Stock Units on September 1, 2026, converting them into an equal number of common shares. To cover related tax obligations, 4,489 common shares were delivered or withheld at $140.34 per share. Following the RSU conversion, Hoge held 92,828 Restricted Stock Units directly, and also had indirect ownership of common stock through Valhalla, LLC and a family trust, with the trust position reported subject to a Section 16 beneficial ownership disclaimer.
Positive
- None.
Negative
- None.
Insider Trade Summary
9,283 shares exercised/converted
Exercise
5 txns
Insider
Hoge Stephen
Role
President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F4 | 9,283 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 9,283 | -- | -- |
| Tax Withholding | Common Stock F2 | 4,489 | $140.34 | $630K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 92,828 contracts (Direct);
Common Stock — 1,489,699 shares (Direct);
Common Stock — 4,116 shares (Indirect, By Valhalla, LLC);
Common Stock — 151,933 shares (Indirect, By Trust)
Footnotes (4)
- F1. Restricted stock units convert into common stock on a one-for-one basis.
- F2. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
- F3. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- F4. 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Key Figures
RSUs exercised: 9,283 units
Shares withheld for taxes: 4,489 shares
Tax withholding price: $140.34 per share
+4 more
7 metrics
RSUs exercised
9,283 units
Restricted Stock Units converting into common stock on September 1, 2026
Shares withheld for taxes
4,489 shares
Common shares delivered or withheld to satisfy tax withholding obligations
Tax withholding price
$140.34 per share
Price applied to the 4,489 common shares withheld for tax liability
RSUs held after transaction
92,828 units
Direct Restricted Stock Unit holdings following the September 1, 2026 conversion
Indirect holdings via Valhalla, LLC
4,116 shares
Common stock held indirectly by Valhalla, LLC as of September 1, 2026
Indirect holdings via trust
151,933 shares
Common stock held indirectly by a family trust subject to a Section 16 ownership disclaimer
RSU vesting schedule initial tranche
25% vested March 1, 2026
First tranche of the RSU award; remainder vests in twelve equal quarterly installments
Key Terms
Restricted Stock Units, tax withholding obligations, Section 16 beneficial ownership, pecuniary interest, +1 more
5 terms
Restricted Stock Units financial
"Restricted Stock Units convert into common stock on a one-for-one basis"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares withheld at the election of the Reporting Person to satisfy tax withholding obligations"
Section 16 beneficial ownership regulatory
"The reporting person disclaims Section 16 beneficial ownership of these securities"
pecuniary interest financial
"except to the extent of his pecuniary interest therein, if any"
vested financial
"25% of the shares subject to this restricted stock unit award vested on March 1, 2026"
FAQ
What equity transaction did Moderna (MRNA) President Stephen Hoge report on September 1, 2026?
He reported the exercise of 9,283 Restricted Stock Units, which converted into an equal number of Moderna common shares, as part of a scheduled vesting of a restricted stock unit award.
How many Restricted Stock Units does Stephen Hoge hold after the reported transaction at Moderna (MRNA)?
After the September 1, 2026 RSU conversion, Stephen Hoge held 92,828 Restricted Stock Units directly, which remain subject to their vesting schedule described in the award footnote.
Was Stephen Hoge’s September 1, 2026 Moderna (MRNA) transaction under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not marked, and the footnotes do not state that the September 1, 2026 transactions were executed pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
